Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

Similar articles for PubMed (Select 8533157)

1.

Cellular responses to DNA damage: cell-cycle checkpoints, apoptosis and the roles of p53 and ATM.

Enoch T, Norbury C.

Trends Biochem Sci. 1995 Oct;20(10):426-30. Review.

PMID:
8533157
2.

p53 and ATM: cell cycle, cell death, and cancer.

Morgan SE, Kastan MB.

Adv Cancer Res. 1997;71:1-25. Review.

PMID:
9111862
3.

ATM: the protein encoded by the gene mutated in the radiosensitive syndrome ataxia-telangiectasia.

Lavin MF, Khanna KK.

Int J Radiat Biol. 1999 Oct;75(10):1201-14. Review.

PMID:
10549596
4.

Fragments of ATM which have dominant-negative or complementing activity.

Morgan SE, Lovly C, Pandita TK, Shiloh Y, Kastan MB.

Mol Cell Biol. 1997 Apr;17(4):2020-9.

5.

Defective control of apoptosis, radiosensitivity, and spindle checkpoint in ataxia telangiectasia.

Takagi M, Delia D, Chessa L, Iwata S, Shigeta T, Kanke Y, Goi K, Asada M, Eguchi M, Kodama C, Mizutani S.

Cancer Res. 1998 Nov 1;58(21):4923-9.

6.

Atm selectively regulates distinct p53-dependent cell-cycle checkpoint and apoptotic pathways.

Barlow C, Brown KD, Deng CX, Tagle DA, Wynshaw-Boris A.

Nat Genet. 1997 Dec;17(4):453-6. Erratum in: Nat Genet 1998 Mar;18(3):298.

PMID:
9398849
7.

ATM: the p53 booster.

Nakamura Y.

Nat Med. 1998 Nov;4(11):1231-2. No abstract available.

PMID:
9809536
8.
9.
10.

ATM: the product of the gene mutated in ataxia-telangiectasia.

Lavin MF.

Int J Biochem Cell Biol. 1999 Jul;31(7):735-40. Review.

PMID:
10467728
11.

Defective p53 response and apoptosis associated with an ataxia-telangiectasia-like phenotype.

Gueven N, Becherel OJ, Birrell G, Chen P, DelSal G, Carney JP, Grattan-Smith P, Lavin MF.

Cancer Res. 2006 Mar 15;66(6):2907-12.

12.

Ataxia telangiectasia-mutated gene product inhibits DNA damage-induced apoptosis via ceramide synthase.

Liao WC, Haimovitz-Friedman A, Persaud RS, McLoughlin M, Ehleiter D, Zhang N, Gatei M, Lavin M, Kolesnick R, Fuks Z.

J Biol Chem. 1999 Jun 18;274(25):17908-17.

13.
14.

ATM to the rescue: repairing DNA damage.

Eckardt NA.

Plant Cell. 2003 Jan;15(1):1-3. No abstract available.

15.

Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner.

Hirao A, Cheung A, Duncan G, Girard PM, Elia AJ, Wakeham A, Okada H, Sarkissian T, Wong JA, Sakai T, De Stanchina E, Bristow RG, Suda T, Lowe SW, Jeggo PA, Elledge SJ, Mak TW.

Mol Cell Biol. 2002 Sep;22(18):6521-32.

16.

Role of cell cycle in mediating sensitivity to radiotherapy.

Pawlik TM, Keyomarsi K.

Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):928-42. Review.

PMID:
15234026
17.

Ataxia-telangiectasia: is ATM a sensor of oxidative damage and stress?

Rotman G, Shiloh Y.

Bioessays. 1997 Oct;19(10):911-7. Review.

PMID:
9363685
18.

Discovery of AT gene sparks biomedical research bonanza.

Nowak R.

Science. 1995 Jun 23;268(5218):1700-1. No abstract available.

PMID:
7792589
19.

Relationship of the ataxia-telangiectasia protein ATM to phosphoinositide 3-kinase.

Lavin MF, Khanna KK, Beamish H, Spring K, Watters D, Shiloh Y.

Trends Biochem Sci. 1995 Oct;20(10):382-3. Review. No abstract available.

PMID:
8533147
20.

Cleavage and inactivation of ATM during apoptosis.

Smith GC, d'Adda di Fagagna F, Lakin ND, Jackson SP.

Mol Cell Biol. 1999 Sep;19(9):6076-84.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk